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Evidence suggests that 3 - 4% of patient encounters in primary 
health care result in blood tests being requested.1 There is 
compelling evidence of significant misuse and poor utilisation 
of many laboratory tests,2 which results in an economic 
burden and other problems including further investigation 
of false-positive results.1 Patients have high expectations that 
blood tests be performed and have little understanding of the 
limitations of testing.3 The frequency of test ordering is much 
higher in the USA and Canada, for example, than in the UK, 
without any overt difference in the quality of care. There are 
suggestions that 30 - 50% of tests are unnecessary, and that 
about 15% of abnormal results are not acted upon.4
Postulates for the differences in testing frequency include the 
threat or perceived fear of medical malpractice litigation, but 
there is evidence that more litigation results from failure to act 
on test results than from not ordering tests a priori.4
Methods to improve test usage have been developed. One 
of the most effective ways is to redesign laboratory request 
forms to allow fewer choices, so reducing the number of 
tests ordered.2 Use of order forms in conjunction with clinical 
practice guidelines is also effective in reducing test ordering.1
Ravensmead Community Health Centre (CHC) serves the 
community of Ravensmead in Parow Valley, Cape Town, as a 
primary health care centre. Health care staff are provided with 
a Spencer haemoglobinometer and a hand-held glucometer 
(Accuchek). Urine testing dipsticks (including for semi-
quantitative ketones) and urine pregnancy tests (Pregnosticon) 
are also available. The supporting laboratory service is 
administered by the National Health Laboratory Service 
(NHLS), and the request forms and guidelines therein form the 
basis for this article.
The request form facing page has a very limited test 
menu, and it clearly states that no further requests should or 
will be entertained unless authorised by the ‘Senior Medical 
Superintendent’.
The reverse of the request form has a section that states: 
‘These recommendations have been developed after wide discussion 
amongst medical officers, clinical nurse practitioners and the NHLS.’ 
This is encouraging as locally developed guidelines tend to 
accurately judge the applicability of evidence to local practice.5 
No mention is made of what evidence the regulations are 
based on, nor does it appear to be based on expert opinion, 
or, if so, it is not stated. The form also lists the rationale 
behind the guidelines for tests requested. We examined these 
recommendations and the discussions. A summary of the 
findings is presented in Table I.
Chemistry
The use of the prostate-specific antigen (PSA) test is 
controversial; many countries advocate the introduction of 
national screening programmes, but routine screening in low-
risk groups is currently not justified.6 However, in symptomatic 
patients it appears to be reasonable to allow PSA requests.
Hypothyroidism is commonly treated with replacement 
by levothyroxine sodium (Eltroxin). It is claimed that, once 
established on a stable dose, annual monitoring, although 
routine, is probably unnecessary except in elderly patients. 
However, many – sometimes approaching half of all 
hypothyroid patients receiving replacement thyroid hormone 
– have abnormal thyroid-stimulating hormone (TSH) results, 
reflecting inappropriate dosing.7 
Cholesterol should be aggressively targeted, and it is 
established practice to measure high-density lipoprotein (HDL) 
cholesterol and low-density lipoprotein (LDL) cholesterol in 
primary care settings and to start statin therapy.8 Currently, 
statin therapy may not be initiated at Ravensmead CHC but 
merely continued, if the prescription had been initiated at a 
specialist clinic.
Rheumatoid arthritis is a common debilitating disease 
which may be difficult to diagnose. Rheumatoid factor is a 
nonspecific marker of inflammation, and is generally used to 
monitor disease activity in rheumatoid arthritis, although with 
caveats.9 It is a test that must be carefully performed to prevent 
erroneous results and is fraught with potential problems.9 The 
injunction against specialised tests for rheumatoid pathology 
appears to be warranted.
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Haematology
The proposed clinical protocol for management of suspected 
anaemia is to make the diagnosis with a hand-held Spencer 
haemoglobinometer, give a trial of iron therapy for 2 
months, and, if that is unsuccessful, refer the patient. The 
Spencer haemoglobinometer has long been used in the 
primary care setting and judged to be an adequate screening 
method for detecting anaemia.10 Unfortunately, there are 
other considerations when providing a point-of-care testing 
device service, including staff training, health and safety 
considerations, quality assurance and ongoing maintenance.11 
Linegar et al. concluded that the haemoglobinometer was 
adequate for South African clinical practice with two caveats: 
firstly, that they obtained results within 5 - 8% agreement 
of an automated result by averaging the readings obtained 
by 3 trained staff, and secondly, that regular calibration was 
mandatory.10
A single haemoglobin measurement has low sensitivity and 
specificity for the diagnosis of iron deficiency.12 Classically, 
the cause of the anaemia is determined to enable appropriate 
therapy. It appears reasonable that attempts to establish a cause 
for low Hb should be supplemented by the mean corpuscular 
volume (MCV) to categorise the type of anaemia and, if 
microcytic, a trial of iron therapy should be attempted; if not 
microcytic, the patient should be referred for investigation.4
C-reactive protein (CRP) is probably superior to erythrocyte 
sedimentation rate (ESR) in the first 24 hours following tissue 
injury and in children. However, ESR is still valid for clinical 
practice but is influenced by many factors, and quality control 
that cannot be achieved in a high-throughput primary health 
care setting is mandatory.13 The full blood count (FBC), white 
cell count (WCC) and differential count allow rapid screening 
for serious disorders, and are some of the most requested 
tests.14
Design of the request form
The request form uses two common and effective methods of 
reducing test requests: offering a limited test menu, and issuing 
guidelines to guide clinical practice.
Although we highlight limitations in the current request 
form, several positives have come from requesting guidelines. 
Firstly, guidelines are effective in changing requesting habits 
and limiting costs and inappropriate testing. Secondly, they 
serve as a useful reference to clinicians as to the utility of 
tests. Thirdly, they assist clinicians to practise best medicine.5 
Fourthly, they remind clinicians of the truth of the old 
aphorism: ‘Common things occur commonly’.
Recommendations
Guidelines should be developed as part of a structured process 
to consistently deliver the best practice of care to patients.5 The 
limitations of the current request forms are varied, and include 
potential de-skilling of doctors. Patients also have expectations 
that should be addressed, one being blood tests. The treating 
clinician and the patient should discuss the indications and 
limitations of testing. Furthermore, the guidelines issued 
must be carefully framed by evidence; if not, they become 
inadequate and, at worst, potentially dangerous. Finally, a risk 
exists that tests that are not listed could be underutilised, even 
if appropriate to that setting.
Several characteristics of guidelines have not been addressed 
in these request forms. Guidelines should be drawn up by an 
Table I. Test request guidelines categorised as adequate or 
inadequate.
                 Comments
Adequate 
INR
Creatinine
Potassium
Lipase
Urate
Total bilirubin
ALT
ALP
GGT
Pregnancy test
HIV
RPR
Drug levels
MCV
Inadequate
PSA                 Should be allowed in symptomatic
                 patients
TSH                 Annual monitoring of all patients
                 on Eltroxin should be allowed
Hb                 Technically able to perform
                 required task but long-term
                 stability dubious if no supporting
                 structures in place
Cholesterol/triglycerides   At odds with evidence-based
                 medicine and international
                 guidelines
FBC                 Indications for FBC are
                 poorly defined
ESR                 Useful for monitoring disease
                 activity but should be performed
                 in a laboratory and not in the
                 clinic as suggested
WCC                 Allows for rapid screening of
                 suspected inflammatory or
                 haematological diseases
ALP = alkaline phosphatase; ALT = alanine transaminase; CRP = C-reactive protein; 
ESR = erythrocyte sedimentation rate; FBC = full blood count; GGT = gamma -
glutamyl transferase; HIV = human immunodeficiency virus; Hb = haemoglobin; 
HDL = high-density lipoprotein; INR = international normalised ratio; LDL = 
low-density lipoprotein; MCV = mean corpuscular volume; PSA = prostate specific 
antigen; RPR = rapid plasma reagin; TSH = thyroid-stimulating hormone; WCC = 
white cell count.
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identified and contactable committee that must identify and 
assess the evidence, translate that evidence into guidelines, 
and critically and explicitly grade the quality of the evidence.15 
With the rapid pace of change in medicine, guidelines should 
be reviewed at regular intervals, and this aspect should be 
reflected in them.5,15 Guidelines should also have clear tools and 
methods to monitor their use through regular audits.5
Overall, the request guidelines were reasonable in limiting 
test requests, but several important shortcomings need to be 
addressed.
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